Impact of somatic mutations on response in patients > 60 years old with newly diagnosed AML treated with responseadapted sequential Azacitidine and induction chemotherapy: results of the DRKS00004519 trial (RAS-AZIC) of the East German study group (OSHO)
ONCOLOGY RESEARCH AND TREATMENT（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要